AbbVie unveils latest round of immunology scholarships for patients with chronic disease
Another 45 students with chronic, immune-mediated diseases are going to college with a little help from AbbVie.
AbbVie announced the recipients of this year’s Immunology Scholarship on Thursday, a group of students who have “exemplified determination to overcome challenges,” AbbVie’s US president of immunology Patrick Horber said in a news release.
While best known for its portfolio of immunology drugs such as Rinvoq, Skyrizi or blockbuster Humira — which faces an impending patent cliff — AbbVie launched its immunology scholarship program back in 2016 to prove its commitment to helping patients outside of filling prescriptions.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.